-
March 23, 2021
Renovacor, Inc. to Merge with Chardan Healthcare Acquisition 2 Corp.
PHILADELPHIA and NEW YORK, March 23, 2021 /PRNewswire/ -- Renovacor, Inc. ("Renovacor" or the "Company"), an early-stage biotechnology company developing AAV-based gene therapies for devastating card...
Read More -
January 25, 2021
Alleviant Medical Receives Breakthrough Device Designation From FDA for Transcatheter Technology
AUSTIN, Texas--(BUSINESS WIRE)--Alleviant Medical Inc., a privately-held medical device company, today announced that the US Food and Drug Administration (FDA) has granted the company a Breakthrough D...
Read More -
December 7, 2020
Basking Biosciences, Inc. Completes $5.4M Seed Financing
December 07, 2020 08:30 AM Eastern Standard Time COLUMBUS, Ohio--(BUSINESS WIRE)--Basking Biosciences, Inc. (Basking), a privately-held biopharmaceutical company developing a next generation trea...
Read More -
November 30, 2020
Vectorious’ in-heart microcomputer wins FDA breakthrough nod
November 30, 2020. Vectorious Medical Technologies today announced that the FDA has granted breakthrough device designation for the company’s left atrial pressure (LAP) monitoring device. The V-L...
Read More -
October 20, 2020
FineHeart Achieves Milestone for its Miniaturized Heart Pump Technology with Successful Completion of 30-Day Preclinical Study
Bordeaux, France - October 20, 2020. – FineHeart, SA, a preclinical-stage medical device company developing an Implantable Cardiac Output Management System (ICOMS) to address the unmet need of...
Read More -
July 22, 2020
FineHeart: An LVAD Works in Synchrony with the Heart
Founded by electrophysiologists, FineHeart has developed an LVAD that is like no other. It resides inside the left ventricle of the heart where it times the blood flow it generates with the opening an...
Read More -
June 12, 2020
ZZ Biotech Announces FDA Fast Track Designation for Stroke Program
HOUSTON, USA, June 12, 2020 / B3C newswire / -- ZZ Biotech today announced that the US Food and Drug Administration (FDA) has designated the investigation of the company’s experimental drug 3K3A-APC...
Read More -
May 27, 2020
Kantum Pharma Highlights New Research Demonstrating Beneficial Effects of P2Y14 Antagonist in Acute Kidney Injury
CAMBRIDGE, Mass., May 27, 2020 /PRNewswire/ -- Kantum Pharma Inc. (Kantum), a biopharmaceutical company focused on developing therapies for the prevention and treatment of damaging inflammation trigge...
Read More -
May 5, 2020
FineHeart Completes First Successful Chronic In-Vivo Study of its ICOMS Device Intended for the Treatment of Severe Heart Failure
Bordeaux, May 5, 2020 – FineHeart, a French medical device company, today announced the success of a seven-day preclinical study to evaluate its Implantable Cardiac Output Management System (ICOMS),...
Read More -
May 7, 2020
Acesion Pharma Strengthens Clinical Team with Key Appointments
Copenhagen, 5 May 2020. Acesion Pharma, a Danish pharmaceutical company developing novel treatments for atrial fibrillation (AF), the most common cardiac arrhythmia, today announced that it has recru...
Read More
